Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harish C Pant

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2006
Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1Tej K Pareek, Jason Keller, Sashi Kesavapany, et al.
Neurochemistry International|May 5, 2005
Nuclear localization of Munc18-1 (p67) in the adult rat brain and PC12 cellsVandana M Sharma, Momin M Shareef, Kiran Bhaskar, et al.
Neurochemistry International|September 10, 2003
Co-purification and localization of Munc18-1 (p67) and Cdk5 with neuronal cytoskeletal proteinsKiran Bhaskar, Mohammed Momin Shareef, Vandana M Sharma, et al.
Neuro-Signals|August 22, 2006
Neuronal nuclear organization is controlled by cyclin-dependent kinase 5 phosphorylation of Ras Guanine nucleotide releasing factor-1Sashi Kesavapany, Tej Kumar Pareek, Ya-Li Zheng, et al.
Molecular Pain|October 4, 2017
Peripheral and orofacial pain sensation is unaffected by the loss of p39Michaela Prochazkova, Bradford Hall, Minghan Hu, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein KinasesB K Binukumar, Steven L Pelech, Catherine Sutter, et al.
The Journal of Biological Chemistry|August 20, 2010
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylationYa-Li Zheng, Niranjana D Amin, Ya-Fang Hu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 4, 2008
Cyclin-dependent kinase 5 phosphorylation of human septin SEPT5 (hCDCrel-1) modulates exocytosisNiranjana D Amin, Ya-Li Zheng, Sashi Kesavapany, et al.
The Analyst|March 12, 2020
Rapid, quantitative therapeutic screening for Alzheimer's enzymes enabled by optimal signal transduction with transistorsSon T Le, Michelle A Morris, Antonio Cardone, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 7, 2004
p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neuronsSashi Kesavapany, Niranjana Amin, Ya-Li Zheng, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2006
Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1Tej K Pareek, Jason Keller, Sashi Kesavapany, et al.
Neurochemistry International|May 5, 2005
Nuclear localization of Munc18-1 (p67) in the adult rat brain and PC12 cellsVandana M Sharma, Momin M Shareef, Kiran Bhaskar, et al.
Neurochemistry International|September 10, 2003
Co-purification and localization of Munc18-1 (p67) and Cdk5 with neuronal cytoskeletal proteinsKiran Bhaskar, Mohammed Momin Shareef, Vandana M Sharma, et al.
Neuro-Signals|August 22, 2006
Neuronal nuclear organization is controlled by cyclin-dependent kinase 5 phosphorylation of Ras Guanine nucleotide releasing factor-1Sashi Kesavapany, Tej Kumar Pareek, Ya-Li Zheng, et al.
Molecular Pain|October 4, 2017
Peripheral and orofacial pain sensation is unaffected by the loss of p39Michaela Prochazkova, Bradford Hall, Minghan Hu, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein KinasesB K Binukumar, Steven L Pelech, Catherine Sutter, et al.
The Journal of Biological Chemistry|August 20, 2010
A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylationYa-Li Zheng, Niranjana D Amin, Ya-Fang Hu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 4, 2008
Cyclin-dependent kinase 5 phosphorylation of human septin SEPT5 (hCDCrel-1) modulates exocytosisNiranjana D Amin, Ya-Li Zheng, Sashi Kesavapany, et al.
The Analyst|March 12, 2020
Rapid, quantitative therapeutic screening for Alzheimer's enzymes enabled by optimal signal transduction with transistorsSon T Le, Michelle A Morris, Antonio Cardone, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 7, 2004
p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neuronsSashi Kesavapany, Niranjana Amin, Ya-Li Zheng, et al.
Pageof 10